Get 20% Off Market Intelligence Reports With Code ONLINE20 – Track Global Tariffs, Economic Shifts, and Sector Transformations
What Is the Growth Potential of the Oral Contraceptive Pills Market in the Next Decade?
The oral contraceptive pills market size has grown rapidly in recent years. It will grow from $26.82 billion in 2024 to $30.43 billion in 2025 at a compound annual growth rate (CAGR) of 13.5%. The growth in the historic period can be attributed to increasing awareness, rising women's health concerns, government initiatives, changing lifestyles, market expansion.
The oral contraceptive pills market size is expected to see rapid growth in the next few years. It will grow to $53.07 billion in 2029 at a compound annual growth rate (CAGR) of 14.9%. The growth in the forecast period can be attributed to growing population, women's empowerment, rising healthcare expenditure, advancements in healthcare infrastructure, expanding product portfolio. Major trends in the forecast period include focus on minimizing side effects and hormonal disruption, emergence of non-hormonal and natural contraceptive alternatives, shift towards continuous and tailored contraceptive regimens, increasing awareness and education initiatives, rise in female empowerment and involvement in contraceptive choices.
Claim your free report sample now:
What Are the Major Drivers Influencing the Oral Contraceptive Pills Market?
The high incidence of unintended pregnancies is expected to drive the growth of the oral contraceptive pills market over the coming years. An unintended pregnancy is a pregnancy that is always unwanted, such as a pregnancy where no children have been planned. The University of California, San Francisco (UCSF) study shows that the rates of unwanted pregnancy and abortion declined substantially when women received a one-year prescription of oral contraceptives. According to the World Health Organization (WHO), 74 million women living in low-middle-income economies register unplanned pregnancies every year globally. The WHO’s research noticed that 4,794 women had unplanned pregnancies after they had discontinued using contraceptives. Therefore, the need to avoid unintended pregnancies drives the growth of the oral contraceptive pills market.
Which Segment Holds the Largest Share in the Oral Contraceptive Pills Market?
The oral contraceptive pills market covered in this report is segmented –
1) By Type: Combination, Progestin Only, Other Types
2) By Category: Generic, Branded
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel And NGO, Other Distribution Channels
Subsegments:
1) By Combination Pills: Monophasic Combination Pills, Multiphasic Combination Pills, Extended-Cycle Combination Pills
2) By Progestin-Only Pills: Daily Progestin-Only Pills, Progestin-Only Emergency Contraceptive Pills
3) By Other Types: Low-Dose Oral Contraceptive Pills, High-Dose Oral Contraceptive Pills, Non-Hormonal Oral Contraceptives (In Development Or Alternative Formulations)
What Are the Major Trends Impacting the Oral Contraceptive Pills Market?
Major institutes and companies operating in the oral contraceptive pill sector are focusing on developing innovative solutions for oral contraceptive pills. For instance, in December 2023, The United Kingdom has begun clinical trials for a male hormone-free contraception pill. This ground-breaking trial establishes the study group in the country as a global leader in studying this novel type of drug. The drug in question, YCT-529, works as a retinoic acid receptor-alpha inhibitor. This medication works by preventing sperm production by blocking vitamin A availability. A team of researchers from the University of Minnesota in Minneapolis created the medication.
Which Major Companies Are Operating in the Oral Contraceptive Pills Market?
Major companies operating in the oral contraceptive pills market include Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Abbvie Inc., Bayer AG, Zydus Lifesciences Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Cipla Inc., Dr. Reddy's Laboratories Ltd., Amneal Pharmaceuticals LLC, Lupin Pharmaceuticals Inc., Glenmark Pharmaceuticals, Mankind Pharma Ltd., Mayne Pharma, HLL Lifecare Limited, Famy Care Ltd., Mylan N.V., Novartis AG, GlaxoSmithKline plc, Piramal Enterprises Ltd., Syzygy Healthcare, V Care Pharma
Get the full oral contraceptive pills market report here:
Which Region Is Expected to Lead the Oral Contraceptive Pills Market by 2029?
North America was the largest region in the oral contraceptive pills market in 2024. The Middle East is expected to be the largest growing region in the forecast period. The regions covered in the oral contraceptive pills market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment